Literature DB >> 25421982

Does low diastolic blood pressure contribute to the risk of recurrent hypertensive cardiovascular disease events? The Framingham Heart Study.

Stanley S Franklin1, Sohum S Gokhale2, Vincent H Chow2, Martin G Larson2, Daniel Levy2, Ramachandran S Vasan2, Gary F Mitchell2, Nathan D Wong2.   

Abstract

Whether low diastolic blood pressure (DBP) is a risk factor for recurrent cardiovascular disease (CVD) events in persons with isolated systolic hypertension is controversial. We studied 791 individuals (mean age 75 years, 47% female, mean follow-up time: 8±6 years) with DBP <70 (n=225) versus 70 to 89 mm Hg (n=566) after initial CVD events in the original and offspring cohorts of the Framingham Heart Study. Recurrent CVD events occurred in 153 (68%) participants with lower DBP and 271 (48%) with higher DBP (P<0.0001). Risk of recurrent CVD events in risk factor-adjusted Cox regression was higher in those with DBP <70 mm Hg versus DBP 70 to 89 mm Hg in both treated (hazard ratio, 5.1 [95% confidence interval: 3.8-6.9] P<0.0001) and untreated individuals (hazard ratio, 11.7 [95% confidence interval: 6.5-21.1] P<0.0001; treatment interaction: P=0.71). Individually, coronary heart disease, heart failure, and stroke recurrent events were more likely with DBP <70 mm Hg versus 70 to 89 mm Hg (P<0.0001). To examine for an effect of wide pulse pressure on excess risk associated with low DBP, we defined 4 binary groupings of pulse pressure (≥68 versus <68 mm Hg) and DBP (<70 versus 70-89 mm Hg). CVD incidence rates were higher only in the group with pulse pressure ≥68 and DBP <70 mm Hg (76% versus 46%-54%; P<0.001). Persons with isolated systolic hypertension and prior CVD events have increased risk for recurrent CVD events in the presence of DBP <70 mm Hg versus DBP 70 to 89 mm Hg, whether treated or untreated, supporting wide pulse pressure as an important risk modifier for the adverse effect of low DBP.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  blood pressure; cardiovascular disease; epidemiology

Mesh:

Substances:

Year:  2014        PMID: 25421982     DOI: 10.1161/HYPERTENSIONAHA.114.04581

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  21 in total

1.  VKORC1 and CD-14 genetic polymorphisms associate with susceptibility to cardiovascular and cerebrovascular diseases.

Authors:  Jian Du; Zhiguo Zhang; Yuanyuan Ge; Juan Zhen; Jiyan Leng; Jianmeng Wang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Hypertension and coronary artery disease: epidemiology, physiology, effects of treatment, and recommendations : A joint scientific statement from the Austrian Society of Cardiology and the Austrian Society of Hypertension.

Authors:  Thomas Weber; Irene Lang; Robert Zweiker; Sabine Horn; Rene R Wenzel; Bruno Watschinger; Jörg Slany; Bernd Eber; Franz Xaver Roithinger; Bernhard Metzler
Journal:  Wien Klin Wochenschr       Date:  2016-06-09       Impact factor: 1.704

3.  Reversion of left ventricle remodeling in spontaneously hypertensive rats by valsartan is associated with the inhibition of caspase-3, -8 and -9 activities.

Authors:  X U Deng; K E Xia; P O Chen; Md Sayed Ali Sheikh; DA-Feng Yang; Si-Min Li; Tian-Lun Yang
Journal:  Biomed Rep       Date:  2015-04-29

Review 4.  J-shaped curve for cardiovascular mortality: systolic or diastolic blood pressure?

Authors:  Nicolás Roberto Robles; Francesco Fici; Guido Grassi
Journal:  J Nephrol       Date:  2018-09-17       Impact factor: 3.902

Review 5.  Thus Far and No Further: Should Diastolic Hypotension Limit Intensive Blood Pressure Lowering?

Authors:  Marcel Ruzicka; Cedric Edwards; Brendan McCormick; Swapnil Hiremath
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-09-14

Review 6.  Arterial stiffness as a risk factor for clinical hypertension.

Authors:  Michel E Safar
Journal:  Nat Rev Cardiol       Date:  2017-10-12       Impact factor: 32.419

7.  Optimal Blood Pressure Thresholds for Minimal Coronary Artery Disease Risk in Type 1 Diabetes.

Authors:  Jingchuan Guo; Maria M Brooks; Matthew F Muldoon; Ashely I Naimi; Trevor J Orchard; Tina Costacou
Journal:  Diabetes Care       Date:  2019-06-27       Impact factor: 19.112

8.  Prevalence of office and ambulatory hypotension in treated hypertensive patients with coronary disease.

Authors:  Juan A Divisón-Garrote; Juan J de la Cruz; Alejandro de la Sierra; Ernest Vinyoles; Manuel Gorostidi; Carlos Escobar-Cervantes; Julián Segura; Vivencio Barrios; Luis M Ruilope; José R Banegas
Journal:  Hypertens Res       Date:  2020-05-12       Impact factor: 3.872

9.  Klf4 has an unexpected protective role in perivascular cells within the microvasculature.

Authors:  Ryan M Haskins; Anh T Nguyen; Gabriel F Alencar; Marie Billaud; Molly R Kelly-Goss; Miranda E Good; Katharina Bottermann; Alexander L Klibanov; Brent A French; Thurl E Harris; Shayn M Peirce; Brant E Isakson; Gary K Owens
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-04-06       Impact factor: 4.733

Review 10.  Wide pulse pressure: A clinical review.

Authors:  Kevin S Tang; Edward D Medeiros; Ankur D Shah
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-28       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.